Back to News
research

Sana Biotechnology, Inc. (SANA) Presents at The Citizens Life Sciences Conference 2026 Transcript

Seeking Alpha
Loading...
2 min read
0 likes
⚡ Quantum Brief
Sana Biotechnology’s CEO Steve Harr presented at the 2026 Citizens Life Sciences Conference in Miami, outlining the company’s vision for transforming medicine over the next two decades through engineered cells. Founded seven years ago, Sana focuses on developing hypoimmune cell platforms to create universal, off-the-shelf therapies, addressing limitations in current cell-based treatments like rejection and scalability. Harr emphasized forward-looking statements, directing investors to the company’s 10-K for risk factors, signaling transparency amid high-stakes biotech innovation and regulatory challenges. The discussion highlighted Sana’s long-term strategy, positioning it as a leader in next-generation cell engineering, though no specific product timelines or trial updates were disclosed. Analyst Reni Benjamin framed the session for mixed audiences, suggesting Sana’s narrative remains pivotal for both industry insiders and newcomers tracking disruptive life sciences advancements.
AI Audio Summary
0:00 / 0:00
Click to play
vecteezy_data-storage-center-quantum-computing-database-cloud_29725802.JPG
Quantum News · Media Library

SA Transcripts159.02K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Sana Biotechnology, Inc. (SANA) The Citizens Life Sciences Conference 2026 March 11, 2026 1:40 PM EDT Company Participants Steven Harr - President, CEO & Director Conference Call Participants Reni Benjamin - Citizens JMP Securities, LLC, Research Division Presentation Reni BenjaminCitizens JMP Securities, LLC, Research Division All right. We'll go ahead and get started. So good afternoon, everyone, and welcome to the second day of the Citizens Life Science Conference for the first time here in Miami. It's my pleasure to introduce Sana Biotechnology and presenting for the company or chatting with us about the company is CEO, Steve Harr. Steve, welcome, and thank you for this. Question-and-Answer Session Reni BenjaminCitizens JMP Securities, LLC, Research Division I never know exactly who's in the audience or who's listening on the webcast, whether they know the Sana story or not. And so I'd love to start off maybe in 2 to 4 minutes with an overview of Sana before we dive into some specific questions. Steven HarrPresident, CEO & Director Sure. First of all, thank you for having me and the company come down here and enjoy beautiful sunny Miami. And thank you to people here in the audience and to those listening online. You probably know before I get started, we will make forward-looking statements and check out our risk factors in our recently filed 10-K. There, we try to do a very thorough job and help you understand all the things that could go -- or many of the things that could go wrong. I don't think we'll ever capture all of them. The -- we do our best. But anyway, Sana is about 7 years old and started with the idea that one of the most important transformations over the next couple of decades will be the

Read Original

Tags

government-funding

Source Information

Source: Seeking Alpha

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.